Literature DB >> 16226850

Patterns of use and harm reduction practices of ecstasy users in Australia.

Kelly Allott1, Jennifer Redman.   

Abstract

Harm reduction refers to the use of strategies to prevent or reduce harmful consequences associated with illicit drug use. There is a paucity of research concerning the harm reduction practices employed by ecstasy users. This study aimed to explore the prevalence, nature and factors associated with harm reduction practices employed by ecstasy users in Australia, with a specific focus on the practice of preloading and postloading--the use of pharmaceuticals and natural products prior and subsequent to ecstasy use. One hundred and sixteen Australian residents aged 18 years and over who had used ecstasy at least once in their lifetime were recruited via convenience sampling, 'snowballing' and via web-based advertisements and completed an anonymous questionnaire. Participants reported using a wide range of strategies for minimising ecstasy-associated harm. The most common strategies used for reducing negative side effects, 'comedown' or neurotoxicity were drinking water, limiting or reducing ecstasy use, taking breaks and taking vitamins or other natural substances. Forty percent of the sample had tested their ecstasy pills for the presence of MDMA. Forty-one percent and 47% of participants had engaged in pre- and postloading, respectively, with the most common pre- and postloading substances being multivitamins, 5-HTP, magnesium and fruit or fruit juice. Younger mean age and 'high' total occasions of ecstasy use was significantly associated with preloading, and 'high' total use and frequency of use was associated with postloading. The results indicate that ecstasy users are aware of the potential for harm associated with ecstasy use and attempt to minimise harm by actively employing strategies. By exploring the pattern of harm reduction practices among ecstasy users, this study has highlighted the need for further research into the efficacy and potential clinical drug interactions associated with such practices, as well as the need for investigation of how such practices may affect patterns of ecstasy use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226850     DOI: 10.1016/j.drugalcdep.2005.09.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.

Authors:  Raminta Daniulaityte; Russel Falck; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2012-03-13

2.  Benzodiazepine dependence among multidrug users in the club scene.

Authors:  Steven P Kurtz; Hilary L Surratt; Maria A Levi-Minzi; Angela Mooss
Journal:  Drug Alcohol Depend       Date:  2011-06-25       Impact factor: 4.492

3.  A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.

Authors:  Matthew G Kirkpatrick; Erik W Gunderson; Audrey Y Perez; Margaret Haney; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2011-06-30       Impact factor: 4.530

4.  Risk management strategies of synthetic cannabis users.

Authors:  Stephanie Campos; Ellen Benoit; Eloise Dunlap
Journal:  Drugs Alcohol Today       Date:  2019-09-02

Review 5.  A structured review of reasons for ecstasy use and related behaviours: pointers for future research.

Authors:  Gjalt-Jorn Ygram Peters; Gerjo Kok
Journal:  BMC Public Health       Date:  2009-07-13       Impact factor: 3.295

6.  Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.

Authors:  Camille Jacinto; Micheline Duterte; Paloma Sales; Sheigla Murphy
Journal:  Int J Drug Policy       Date:  2007-10-26

7.  Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.

Authors:  Gjalt-Jorn Ygram Peters; Gerjo Kok; Herman P Schaalma
Journal:  BMC Public Health       Date:  2008-10-28       Impact factor: 3.295

Review 8.  Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review.

Authors:  Gjalt-Jorn Y Peters; Gerjo Kok; Charles Abraham
Journal:  Addiction       Date:  2007-11-12       Impact factor: 6.526

9.  Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices.

Authors:  Babak Eshrati; Rahim Taghizadeh Asl; Colleen Anne Dell; Parviz Afshar; Peggy Margaret E Millson; Mohammad Kamali; John Weekes
Journal:  Harm Reduct J       Date:  2008-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.